Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus
Authors
Keywords
-
Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 61, Issue -, Pages 21-27
Publisher
Elsevier BV
Online
2021-09-22
DOI
10.1016/j.coph.2021.08.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
- (2021) Robert Wagner et al. NATURE MEDICINE
- Multifactorial treatment of diabetic patients with cardiovascular disease to maximize results
- (2021) Vasilios Gabriel Athyros JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of statins on mitochondrial pathways
- (2021) Hamid Mollazadeh et al. Journal of Cachexia Sarcopenia and Muscle
- Ceramides and other sphingolipids as drivers of cardiovascular disease
- (2021) Ran Hee Choi et al. Nature Reviews Cardiology
- Machine learning and statistical approaches for classification of risk of coronary artery disease using plasma cytokines
- (2021) Seema Singh Saharan et al. BioData Mining
- Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine 1-Phosphate
- (2020) Makoto Kurano et al. DIABETES
- Role of gut microbiota in type 2 diabetes pathophysiology
- (2020) Manoj Gurung et al. EBioMedicine
- Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors
- (2020) David Preiss et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
- (2020) Edward K. Duran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins and PCSK9 inhibitors: A new lipid-lowering therapy
- (2020) Enrique Gallego-Colon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The alterations of mitochondrial DNA in coronary heart disease
- (2020) Haochang Hu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance
- (2020) Biagio Arcidiacono et al. EBioMedicine
- Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
- (2020) Jeanne Guitton et al. Cells
- Mitochondrial dysfunction in metabolic syndrome
- (2020) Pankaj Prasun BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hypertriglyceridemia
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction
- (2020) A. Maharaj et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
- (2020) Chainika Khatana et al. Oxidative Medicine and Cellular Longevity
- Circular RNAs: Rising stars in lipid metabolism and lipid disorders
- (2020) Guangli Yu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis
- (2019) Sarah A. Aroner et al. DIABETOLOGIA
- Dyslipidemia management in diabetes
- (2019) Julieta Lazarte et al. Canadian Journal of Diabetes
- Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
- (2019) Jenny E. Kanter et al. JOURNAL OF CLINICAL INVESTIGATION
- What lipodystrophies teach us about the metabolic syndrome
- (2019) Jake P. Mann et al. JOURNAL OF CLINICAL INVESTIGATION
- REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States
- (2019) Deepak L. Bhatt et al. CIRCULATION
- Apolipoprotein M
- (2019) Geneviève Tavernier et al. CURRENT OPINION IN LIPIDOLOGY
- Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
- (2019) A. Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool
- (2018) Jacob V. Stidsen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities
- (2018) Baris Akinci et al. Current Diabetes Reports
- Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease
- (2018) Iram Hussain et al. PATHOLOGY
- Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?
- (2017) Baohai Shao et al. Expert Review of Proteomics
- Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients
- (2017) Alex G. Quinn et al. Journal of Clinical Lipidology
- Hypertriglyceridaemia and risk of coronary artery disease
- (2017) Željko Reiner Nature Reviews Cardiology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA Regulation of Atherosclerosis
- (2016) Mark W. Feinberg et al. CIRCULATION RESEARCH
- Apolipoprotein CIII is a new player in diabetes
- (2016) Lisa Juntti-Berggren et al. CURRENT OPINION IN LIPIDOLOGY
- Maturity-onset diabetes of the young (MODY): an update
- (2015) Ahmet Anık et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
- (2013) S. Kaptoge et al. EUROPEAN HEART JOURNAL
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Genetic Syndromes of Severe Insulin Resistance
- (2011) Robert K. Semple et al. ENDOCRINE REVIEWS
- Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus
- (2011) Eusebio Chiefari JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease
- (2011) Xavier Rousset et al. Current Opinion in Endocrinology Diabetes and Obesity
- HDL in humans with cardiovascular disease exhibits a proteomic signature
- (2010) Tomáš Vaisar et al. CLINICA CHIMICA ACTA
- Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes
- (2010) Jianqiu Pan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein M predicts pre-β-HDL formation: studies in type 2 diabetic and nondiabetic subjects
- (2009) P. Plomgaard et al. JOURNAL OF INTERNAL MEDICINE
- Analysis of 17,576 Potentially Functional SNPs in Three Case–Control Studies of Myocardial Infarction
- (2008) Dov Shiffman et al. PLoS One
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
- Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study
- (2007) Dov Shiffman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started